We are live on ! Find out more
CAL

Capital Analysts LLC Portfolio holdings

AUM $4.34B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
+5.93%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+184.17%
AUM
$1.49B
AUM Growth
+$42M
Cap. Flow
-$39.8M
Cap. Flow %
-2.67%
Top 10 Hldgs %
37.93%
Holding
1,129
New
66
Increased
309
Reduced
305
Closed
191

Sector Composition

Rank Sector Weight
1 Technology 6.96%
2 Financials 4.91%
3 Healthcare 4.46%
4 Industrials 3.51%
5 Consumer Discretionary 2.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSPS icon
126
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$247M
$2.39M 0.16%
74,040
+19,145
+35% +$621K
CSCO icon
127
Cisco
CSCO
$479B
$2.37M 0.16%
44,720
-1,537
-3% -$80.9K
SNPS icon
128
Synopsys
SNPS
$79.7B
$2.35M 0.16%
8,535
+395
+5% +$100K
EQIX icon
129
Equinix
EQIX
$103B
$2.35M 0.16%
2,924
+155
+6% +$115K
BLK icon
130
Blackrock
BLK
$176B
$2.34M 0.16%
2,677
-300
-10% -$253K
MOAT icon
131
VanEck Morningstar Wide Moat ETF
MOAT
$12.3B
$2.3M 0.15%
31,114
+4,030
+15% +$293K
IUSG icon
132
iShares Core S&P US Growth ETF
IUSG
$33.9B
$2.3M 0.15%
22,800
+7,754
+52% +$747K
IJT icon
133
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.41B
$2.26M 0.15%
17,072
-1,152
-6% -$150K
EA
134
DELISTED
Electronic Arts
EA
$2.24M 0.15%
15,552
+854
+6% +$121K
RSPH icon
135
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$784M
$2.24M 0.15%
76,360
-15,160
-17% -$429K
TMO icon
136
Thermo Fisher Scientific
TMO
$220B
$2.23M 0.15%
4,423
-18
-0.4% -$8.49K
ARKK icon
137
ARK Innovation ETF
ARKK
$6.29B
$2.19M 0.15%
16,719
+856
+5% +$99.8K
BSX icon
138
Boston Scientific
BSX
$71.5B
$2.19M 0.15%
51,150
+11,872
+30% +$499K
HYDW icon
139
Xtrackers Low Beta High Yield Bond ETF
HYDW
$67.5M
$2.18M 0.15%
42,849
+4,799
+13% +$243K
SSNC icon
140
SS&C Technologies
SSNC
$18.6B
$2.18M 0.15%
30,226
+1,604
+6% +$117K
SRLN icon
141
State Street Blackstone Senior Loan ETF
SRLN
$5.36B
$2.17M 0.15%
46,895
+15,556
+50% +$715K
NOC icon
142
Northrop Grumman
NOC
$81.2B
$2.17M 0.15%
5,961
+881
+17% +$317K
IUSV icon
143
iShares Core S&P US Value ETF
IUSV
$27.7B
$2.14M 0.14%
29,783
+9,583
+47% +$689K
PXD
144
DELISTED
Pioneer Natural Resource Co.
PXD
$2.14M 0.14%
13,158
+721
+6% +$113K
MCD icon
145
McDonald's
MCD
$195B
$2.02M 0.14%
8,726
-487
-5% -$113K
CVS icon
146
CVS Health
CVS
$122B
$1.98M 0.13%
23,695
+59
+0.2% +$4.83K
VZ icon
147
Verizon
VZ
$196B
$1.98M 0.13%
35,291
-4,180
-11% -$240K
KO icon
148
Coca-Cola
KO
$375B
$1.97M 0.13%
36,406
-1,000
-3% -$54.4K
VTIP icon
149
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
$1.96M 0.13%
37,331
+36,833
+7,396% +$1.92M
MTH icon
150
Meritage Homes
MTH
$4.86B
$1.94M 0.13%
41,278
+2,252
+6% +$114K

Similar funds

Capital Analysts LLC's Q2 2021 Portfolio in Review

As of Q2 2021, Capital Analysts LLC held 1,129 positions worth $1.49B, up 2.9% from $1.45B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Capital Analysts LLC's Q2 2021 filing shows 66 new, 309 increased, 305 reduced and 191 closed positions. Its largest new stake was Warner Bros: 61,167 shares worth $1.88M. The largest sale was iShares Core S&P Total US Stock Market ETF, an estimated $15.9M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.7% a quarter earlier, followed by Financials and Healthcare.

  • Capital Analysts LLC's largest Q2 2021 buy was Warner Bros: 61,167 shares worth $1.88M.
  • Capital Analysts LLC added most to Xtrackers USD High Yield Corporate Bond ETF in Q2 2021, an estimated $9.75M increase.
  • Capital Analysts LLC's biggest Q2 2021 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $15.9M.
  • Capital Analysts LLC fully exited Splunk Inc in Q2 2021, selling an estimated $1.54M.
  • Capital Analysts LLC's ten largest holdings make up 38% of its $1.49B portfolio in Q2 2021.
  • Capital Analysts LLC opened 66 new positions and closed 191 in Q2 2021.
  • Capital Analysts LLC's portfolio value rose 2.9% quarter-over-quarter to $1.49B.

Based on Capital Analysts LLC's 13F filing for Q2 2021, filed 5 Aug 2021.